Recent Finacing
Recent Raise
BlackThorn Therapeutics is a clinical-stage biopharmaceutical developing targeted treatments for neurobehavioral disorders using the INFORM platform linking functional brain imaging to behavior, advancing NOPR antagonist BTRX-246040 into Phase 2.
